Israel has made significant theoretical and practical contributions to the
biotechnology revolution and has developed an advanced infrastructure of medical
and paramedical research as well as bioengineering capabilities. Biotechnology,
biomedical, and clinical research account for over half of all scientific
publications. The country’s industrial sector has increased its activities in
the medical field to capitalize on its extensive knowledge base.
Local scientists have developed methods for producing a human growth hormone
and interferon, a group of proteins effective against viral infections.
Copaxone, a medicine effective in the treatment of multiple sclerosis, was
developed in Israel - from basic research to industrial production. Genetic
engineering, has resulted in a wide range of diagnostic kits based on monoclonal
antibodies, along with other microbiological products.
Sophisticated medical equipment for both diagnostic and treatment purposes
has been developed and marketed worldwide, such as computer tomography (CT)
scanners, magnetic resonance imaging (MRI) systems, ultrasound scanners, nuclear
medical cameras, and surgical lasers. Other innovations include a
controlled-release liquid polymer to prevent accumulation of tooth plaque, a
device to reduce both benign and malignant swellings of the prostate gland, the
use of botulin to correct eye squint, and a miniature camera encased in a
swallowable capsule used to diagnose gastro-intestinal disease.